Temasek Goes for Another Prize

The next big acquisition by Singapore’s giant sovereign wealth fund, Temasek Holdings, is understood to be a 20-percent stake in the privately controlled Zuellig group, a low-profile but very successful pharmaceutical distributor — the largest in Southeast Asia, say Singapore-based corporate sources.

Read →

Comments on this post are for paying subscribers